TherapeuticsMD (TXMD) Inventory Average (2012 - 2022)

TherapeuticsMD has reported Inventory Average for 10 years, with the latest figure at $6.4 million in Q3 2022.

• For the quarter ending Q3 2022, Inventory Average fell 13.96% year-over-year to $6.4 million; the trailing twelve-month figure through Sep 2022 stood at $6.4 million (down 13.96% YoY), and the FY2021 full-year result was $7.8 million, down 21.35% from the prior year.
• Inventory Average for Q3 2022 stood at $6.4 million, down from $7.6 million in the prior quarter.
• The five-year high for Inventory Average was $13.2 million in Q1 2020, with the low at $1.6 million in Q1 2018.
• Historically, Inventory Average has averaged $7.1 million across 5 years, with a median of $7.5 million in 2021.
• Annual changes were most pronounced in 2019 — Inventory Average jumped 323.3% — and 2021, when it tumbled 42.05%.
• TherapeuticsMD's Inventory Average stood at $2.8 million in 2018, then soared by 296.63% to $11.2 million in 2019, then slipped by 19.95% to $9.0 million in 2020, then declined by 16.41% to $7.5 million in 2021, then decreased by 14.24% to $6.4 million in 2022.
• The last three Inventory Average figures came in at $6.4 million (Q3 2022), $7.6 million (Q2 2022), and $8.3 million (Q1 2022), per Business Quant data.